Here's the latest variant picture for Europe (excluding the UK), to mid-March.

The XEC.* variant remains dominant, but it has declined to around 32% frequency.

The LP.8.1.* variant grew to around 22%.

#COVID19 #EUR #XEC #LP_8_1

Here's the latest variant picture for the United Kingdom, to late-March.

The XEC.* variant remains dominant, but it is generally declining to around 50% frequency.

Growth of the LP.8.1.* variant seemed to accelerate in the recent samples, to around 28%.

#COVID19 #UK #XEC #LP_8_1

Here's the latest variant picture for Canada to mid-March. Further samples been back-filled from Ontario, for a more complete picture.

The XEC.* variant is still dominant but has declined to 34%.

The LP.8.1.* variant is challenging at around 24%, probably overhauling the JN.1.* + DeFLuQE variants.

There might be some recent rebound in the FLuQE and FLiRT variants, as unfettered variant evolution continues.

#COVID19 #Canada #XEC #LP_8_1

Here's the latest variant picture for the United States, to mid-March.

The LP.8.1.* variant growth might be wobbling a bit, at around 47%.

The XEC.* variant has declined to around 21%.

#COVID19 #USA #XEC #LP_8_1

Here's the latest variant picture for Australia, to mid-March.

XEC.* continues to dominate, although fairly flat at around 50-60%.

The LP.8.1.* variant grew to around 17%, challenging the DeFLuQE variants as the new heir-apparent. It’s growth trajectory is quite slow.

#COVID19 #Australia #XEC #LP_8_1 @auscovid19

Here's the latest variant picture with a global scope, to mid- March.

Growth of the LP.8.1.* variant seemed to plateau at around 34%, with the XEC.* variant declining to 30%. Recent sample sizes are smaller so this might not be representative.

#COVID19 #Global #XEC #LP_8_1

#CoronaHeadsUp on X wrote:

UK: Covid hospitalisations jump 19% in a week

"..the new dominant LP.8.1 variant may be driving a new wave of the virus"

https://inews.co.uk/news/science/new-covid-wave-cases-hospitalisations-3611459

#LP_8_1

@ABScientist @roelgrif @Cyclad

Here's the latest variant picture for Europe (excluding the UK), to early March.

The XEC.* variant remains dominant, but it has declined to around 31% frequency.

The LP.8.1.* variant grew to around 23%.

Note the recent sample volumes are very low, so this might not be a representative picture.

#COVID19 #EUR #XEC #LP_8_1

Here's the latest variant picture for the United Kingdom, to early March.

The XEC.* variant remains dominant, but it is generally declining to around 50% frequency.

The LP.8.1.* variant is slowly growing, at around 15%.

#COVID19 #UK #XEC #LP_8_1

Here's the latest variant picture for the United States, to mid-March.

The LP.8.1.* variant has continued to grow steadily to around 49%.

The XEC.* variant continued to fall, down to around 19%.

#COVID19 #USA #XEC #LP_8_1

Here's the latest variant picture for New Zealand, to mid-March.

DeFLuQE variants continue to dominate, with the LP.8.1.* variant up to 18%, competing with XEC.*.

#COVID19 #NZ #DeFLuQE #XEC #LP_8_1

Here's the latest variant picture for Australia, to early March.

XEC.* continues to dominate, although fairly flat at around 50-60%.

The LP.8.1.* variant grew to around 18%, finally challenging the DeFLuQE variants as the new challenger.

#COVID19 #Australia #XEC #LP_8_1 @auscovid19

Here's the latest variant picture with a global scope, to mid- March.

The LP.8.1.* variant grew to around 38%, taking over dominance from the declining XEC.* variant.

#COVID19 #Global #XEC #LP_8_1

Here's the latest variant picture for Europe (excluding the UK), to early March.

The XEC.* variant remains dominant, but it has declined to around 48% frequency.

The LP.8.1.* variant grew recently to 20%, passing the other contenders.

#COVID19 #EUR #XEC #LP_8_1

Here's the latest variant picture for the United Kingdom, to early March.

The XEC.* variant remains dominant, but it has fallen to around 44% frequency.

The LP.8.1.* variant grew somewhat to 21%, but then fell back in recent samples to finish at around 17%.

#COVID19 #UK #XEC #LP_8_1

Here's the latest variant picture for the United States, to early March.

The LP.8.1.* variant has continued to grow steadily to around 44%.

The XEC.* variant continued to fall, down to around 24%.

#COVID19 #USA #XEC #LP_8_1

Here's the latest variant picture for New Zealand.

DeFLuQE variants continue to dominate, with the LP.8.1.* variant showing some strong recent growth to 24%, apparently overtaking XEC.*.

#COVID19 #NZ #DeFLuQE #XEC #LP_8_1

Here's the latest variant picture for Australia.

XEC.* continues to dominate by early March, although growth is fairly flat at around 50-60%.

The LP.8.1.* variant grew slowly to around 12%. Globally, this looks like the most likely challenger.

#COVID19 #Australia #XEC #LP_8_1 @auscovid19

Here's the latest variant picture with a global scope.

The XEC.* variant has continued to decline, down to 34% by early March. Meanwhile the LP.8.1.* variant grew to around 28%.

#COVID19 #Global #XEC #LP_8_1

Here's the latest variant picture for the United Kingdom.

The XEC.* variant remains dominant, but growth has stalled at around 60% frequency.

The LP.8.1.* variant grew somewhat to 19% frequency, but then fell back in recent samples to finish at around 15%.

#COVID19 #UK #XEC #LP_8_1